Crinetics Pharmaceuticals is a clinical-stage biotech company committed to the discovery and development of novel small molecule therapeutics for endocrine diseases and endocrine-related cancers. By leveraging a deep understanding of hormone signaling pathways, the company aims to provide oral alternatives to injectable therapies, significantly improving the treatment landscape for patients worldwide.
The company prides itself on a science-first culture, supported by a team of world-class experts in drug discovery and development. Crinetics cultivates an inclusive and collaborative environment that encourages employees to take ownership of their work while making a tangible difference in the lives of patients suffering from complex endocrine conditions.